NCT03828318View on ClinicalTrials.gov

Impact of a Patient-Centered Program for Low Anterior Resection Syndrome a Multicenter Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Rectal CancerSurgeryPatient ActivationLow Anterior ResectionLow Anterior Resection Syndrome
Interventions
OTHER

Patient Activation Booklet and nursing support for patients with LARS

The LARS Patient-Centered Program will consist of an educational booklet and nursing support made available only to patients randomized to the intervention group.

Trial Locations (6)

02114

Massachusetts General Hospital, Boston

Unknown

Providence Healthcare, Vancouver

University of Manitoba, Winnipeg

McGill University Health Centre, Montreal

CHU de Quebec, Québec

H3T 1E2

Jewish General Hospital, Montreal

All Listed Sponsors
collaborator

Providence Healthcare

OTHER

collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

collaborator

Centre Hospitalier du Quebec

UNKNOWN

collaborator

University of Manitoba

OTHER

lead

Jewish General Hospital

OTHER

NCT03828318 - Impact of a Patient-Centered Program for Low Anterior Resection Syndrome a Multicenter Randomized Controlled Trial | Biotech Hunter | Biotech Hunter